Shengda Bio-pharm's biotin obtains premarket approval in South Korea

On 1 Nov., Zhejiang Shengda Bio-pharm Co., Ltd. (Shengda Bio-pharm) announced that its biotin obtained the Premarket Approval for API Drugs in South Korea, which was recently granted by the Ministry of Food and Drug Safety, the Republic of Korea. Thi...

Vitamins China E-News 202111

www.cnchemicals.com